| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Acute Myelogenous Leukemia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Leukemia | |||||
| Leukemia, Myeloid | |||||
| Leukemia, Myeloid, Acute | |||||
| 3 | More general conditions related to this trial | ||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| 4 | Interventions listed in this trial | ||||
| cenersen sodium (EL625) | |||||
| Idarubicin | |||||
| Ara-C | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Cytarabine | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Infective Agents | |||||
| Antibiotics, Antineoplastic | |||||
| Antimetabolites | |||||
| Antimetabolites, Antineoplastic | |||||
| Antineoplastic Agents | |||||
| Antiviral Agents | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Eleos, Inc. | |||||
|
